secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tyra Biosciences, Inc. (TYRA)
CIK:        0001863127
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001193125-24-133170
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tyra Biosciences appoints Drs. Moran and Rothenberg to Board; Dr. Chen resigns
------------------------------------------------------------------------------

- Isan Chen resigned from Board and Compensation Committee effective May 7, 2024, with no disagreement.
- Board expanded from nine to ten and appointed Susan Moran (former CMO, RayzeBio) and S. Michael Rothenberg (CMO, insitro) as directors.
- Moran appointed to Compensation and Science/Technology Committees; Rothenberg to Science/Technology Committee.
- Each new director received options for 37,200 shares vesting over 36 months plus cash compensation.
- Both directors are deemed independent under Nasdaq listing standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/0001193125-24-133170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1863127/000119312524133170/d822217d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-133170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer